Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Marshall Urist currently holds 18,197 shares of Royalty Pharma plc (RPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marshall Urist has been a net seller of RPRX stock. They have purchased $0 and sold $14.0M worth of shares.
Marshall Urist's most recent insider trade was on May 20, 2026, when they sold 13,684 shares at $52.75 per share.
Marshall Urist serves as Executive at Royalty Pharma plc (RPRX). They have executed 27 insider transactions totaling $14.0M over their tenure at the company.
Marshall Urist holds the position of Executive at Royalty Pharma plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Marshall Urist has shown a selling trading pattern, with $0 in total purchases and $14.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Marshall Urist was on Jun 24, 2022, when they sold $1.0M worth of RPRX shares. This transaction involved 23,333 shares at $43.19 per share.
Marshall Urist currently owns 18,197 shares of Royalty Pharma plc (RPRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Marshall Urist's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Marshall Urist has 27 Form 4 filings on record as an insider at Royalty Pharma plc.
Set alerts for Marshall Urist and 40,000+ other insiders.